Sector
PharmaceuticalsOpen
₹1,358Prev. Close
₹1,343.6Turnover(Lac.)
₹233.19Day's High
₹1,360Day's Low
₹1,33552 Week's High
₹1,58052 Week's Low
₹889Book Value
₹161.15Face Value
₹10Mkt Cap (₹ Cr.)
25,458.98P/E
80.16EPS
16.74Divi. Yield
0.22
According to Emcure, the deal was cleared by its board and will be settled in cash. The payments may happen in one or more parts, depending on the closure timeline.
EBITDA margin slightly declined, down 80 basis points to 20.8% in Q2, reflecting some operational pressures.
The allotment of shares was finalised on July 8, and Emcure Pharma shares were scheduled to be listed on the BSE and NSE on July 10.
The IPO comprised a mix of fresh equity sale and an offer for sale (OFS).
The categories earmarked for NII and QIB investors received the most subscriptions, at 47.98 and 193.06 times, respectively.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 181.15 | 180.85 | 180.85 | 180.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,753.95 | 1,661.02 | 1,531.68 | 2,120.92 |
Net Worth | 1,935.1 | 1,841.87 | 1,712.53 | 2,301.77 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 67.26 | 56.99 | 45.91 | 63.47 | 35.39 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,662.5 | 93.09 | 3,98,685.5 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,636 | 79.71 | 1,76,074.69 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,499.1 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,317.9 | 20.56 | 1,09,971.43 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,165.5 | 56.22 | 1,07,116.56 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director
MUKUND KESHAO GURJAR
Whole Time Director
SUNIL RAJNIKANT MEHTA
Managing Director & CEO
SATISH RAMANLAL MEHTA
Chairman & Independent Directo
Berjis M Desai
Whole Time Director
NAMITA VIKAS THAPAR
Independent Director
P S Jayakumar
Independent Director
Vijay Gokhale
Independent Director
Vidya Rajiv Yeravdekar
Non Executive Director
Samonnoi Banerjee
Independent Director
Shailesh Ayyangar
Whole-time Director
SAMIT SATISH MEHTA
Company Sec. & Compli. Officer
CHETAN RAJENDRA SHARMA
Plot # P-1 & P-2 IT BT Park,
Phase II MIDC Hinjawadi,
Maharashtra - 411057
Tel: +91 20 3507 0033/+91 20 3507 0000
Website: http://www.emcure.com
Email: investors@emcure.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited, as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Re...
Read More
Reports by Emcure Pharmaceuticals Ltd
What is the Emcure Pharmaceuticals Ltd share price today?
What is the Market Cap of Emcure Pharmaceuticals Ltd?
What is the PE and PB ratio of Emcure Pharmaceuticals Ltd?
What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd?
What is the CAGR of Emcure Pharmaceuticals Ltd?
What is the shareholding pattern of Emcure Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
